What is the cut off for diagnosing Intrauterine Growth Restriction (IUGR) in an anomaly scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cut-off for Diagnosing IUGR in Anomaly Scan

Intrauterine growth restriction (IUGR) is defined as sonographic estimated fetal weight (EFW) below the 10th percentile for gestational age. 1

Diagnostic Criteria

  • IUGR is diagnosed when the EFW is below the 10th percentile for gestational age and/or abdominal circumference (AC) is below the 10th percentile 1
  • Severe IUGR is defined as EFW below the 3rd percentile 1
  • IUGR should be differentiated from small for gestational age (SGA), as IUGR implies a pathologic process behind the low fetal weight 2, 3

Additional Parameters to Confirm Pathological Growth Restriction

  • Abnormal umbilical artery Doppler (pulsatility index, resistance index, or systolic-to-diastolic ratio greater than the 95th percentile for gestational age) 1
  • Absent or reversed end-diastolic velocity (AEDV or REDV) in the umbilical artery 1
  • Reduced growth velocity (change in AC of <5 mm over 14 days or AC/EFW crossing centiles with >30% reduction) 1
  • Oligohydramnios 4

Classification Based on Timing

  • Early-onset IUGR: Diagnosed at <32 weeks gestation 1
  • Late-onset IUGR: Diagnosed at ≥32 weeks gestation 1

Management After Diagnosis

  • Once IUGR is diagnosed, serial umbilical artery Doppler assessment should be performed to assess for deterioration 1

  • Initial assessment should occur every 1-2 weeks 1

  • If umbilical artery Doppler remains normal after initial assessment, a less frequent interval (every 2-4 weeks) may be considered 1

  • For EFW between 3rd-9th percentile with normal umbilical artery Doppler, follow-up should include:

    • Umbilical artery Doppler every 1-2 weeks initially, then every 2-4 weeks if stable 1
    • Cardiotocography (CTG) once per week 1
    • EFW assessment every 3-4 weeks 1
  • For severe IUGR (EFW <3rd percentile):

    • Weekly umbilical artery Doppler evaluation 1
    • Weekly CTG 1
    • Consider EFW assessment every 2 weeks 1

Important Considerations

  • Umbilical artery Doppler evaluation helps differentiate the hypoxic growth-restricted fetus from the non-hypoxic small fetus, reducing unnecessary interventions 1

  • For pregnancies with abnormal umbilical artery Doppler (AEDV/REDV), more intensive monitoring is required:

    • Doppler assessment 2-3 times per week for AEDV 1
    • For REDV, consider hospitalization, antenatal corticosteroids, and daily CTG monitoring 1
    • Hospital admission should be considered if fetal surveillance more often than 3 times per week is deemed necessary 1
  • Early-onset IUGR (<32 weeks) may warrant genetic testing:

    • Consider chromosomal microarray analysis (CMA) when IUGR is accompanied by fetal malformations or polyhydramnios 1
    • CMA should be offered for unexplained isolated IUGR diagnosed at <32 weeks gestation (4-10% incremental yield over karyotype) 1

Common Pitfalls to Avoid

  • Not distinguishing between IUGR and SGA - IUGR implies a pathologic process and carries higher risks of perinatal morbidity and mortality 2, 5
  • Relying solely on EFW without considering Doppler studies - the combination of biometry and Doppler provides better diagnostic accuracy 4
  • Inadequate follow-up frequency - early detection of deterioration is crucial for optimizing outcomes 1
  • Failure to consider the etiology of IUGR, which can include maternal, placental, fetal, and genetic factors 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.